Meningococcal group
Ended Purchase Order Awarded
- Contract number
- SPE2DP25P0556
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $41,796
Award facts
- Opportunity
-
- Meningococcal group Solicitation · SPE2DP25Q0184 · Posted Jul 15, 2025
- Contract value 100% obligated
- $41,795.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price purchase order valued at $41,795.96 by the Defense Logistics Agency's Medical Supply Chain division on July 21, 2025. The contract, designated as a Total Small Business set-aside, covers the supply of meningococcal group vaccines and related pharmaceutical products. The award was issued rapidly following a solicitation posted on July 15, 2025, with a due date of July 18, 2025, indicating a competitive procurement process tailored for small business participation.
This purchase order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued at approximately $500 million through November 2026, which establishes the company as a critical supplier within the federal pharmaceutical supply chain. The company's extensive portfolio with the Department of Defense includes distribution of prescription medications, biologics, vaccines, and medical consumables to military healthcare facilities nationwide. The meningococcal vaccine delivery fulfills ongoing medical supply requirements for the defense healthcare system, with an ultimate completion date of August 5, 2025, ensuring timely delivery to support military personnel medical readiness and immunization programs.
Quick answers
Who was awarded contract SPE2DP25P0556?
SPE2DP25P0556 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 21, 2025.
How much is contract SPE2DP25P0556 worth?
The government has obligated $41,796 on SPE2DP25P0556.
Was contract SPE2DP25P0556 competed?
The extent of competition for SPE2DP25P0556 was competed under sap. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award